Dyadic International Inc, DE (DYAI) Unusual Options Activity Today

Checking DYAI unusual options activity helps you spot when traders are making outsized bets on Dyadic International Inc, DE before the broader market catches on. Dyadic International Inc, DE's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor DYAI unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching DYAI unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking DYAI unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and DYAI unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates.

The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Catalysts rarely arrive without a footprint, and DYAI unusual options activity is often where that footprint shows up first. Our scanner tracks Dyadic International Inc, DE's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at DYAI unusual options volume on the call side or chasing put sweeps, Dyadic International Inc, DE's unusual options flow today is one click away, so put it on your radar before the headlines hit.